Skip to content

Wednesday, October 28, 2026

Data from SEC filings, checked daily

Public filings, plainly told

About Method Sources Newsletter

Insider tradingForm 4

Helus Pharma Inc. (HELP) Insider Trading

9 open-market trades reported since Sep 9, 2026: 9 purchases worth $9.67M and 0 sales worth $0.

By insider

Insider	Role	Buys	Bought	Sells	Sold	Latest
Greg Cavers	CFO	1	$39K	0	$0	Oct 1, 2026
Michael Halstead	CEO	1	$1.35M	0	$0	Sep 21, 2026
Paul Glavine	Chief Growth Officer	4	$4.72M	0	$0	Sep 11, 2026
Eric H. L. So	Executive Chair	3	$3.57M	0	$0	Sep 11, 2026

All trades

HELP insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	3 mo. after	Filing
Oct 1	Sep 29	Greg CaversCFO	CFO (ind.)	▲ BUY	3,000	12.91	$39K	New		Form 4 ↗
Sep 21	Sep 21	Michael HalsteadCEO	CEO	▲ BUY	100,000	13.47	$1.35M	+146%		Form 4 ↗
Sep 11	Sep 8	Paul GlavineChief Growth Officer	Chief Growth Officer	▲ BUY	100,000	12.47	$1.25M	+2.4%		Form 4 ↗
Sep 11	Sep 8	Paul GlavineChief Growth Officer	Chief Growth Officer	▲ BUY	100,000	12.47	$1.25M	+2.4%		Form 4 ↗
Sep 11	Sep 8	Eric H. L. SoExecutive Chair	Executive Chair	▲ BUY	100,000	12.39	$1.24M	+2.3%		Form 4 ↗
Sep 10	Sep 4	Eric H. L. SoExecutive Chair	Executive Chair	▲ BUY	100,000	12.09	$1.21M	+2.3%		Form 4 ↗
Sep 10	Sep 3	Paul GlavineChief Growth Officer	Chief Growth Officer	▲ BUY	100,000	11.78	$1.18M	+2.5%		Form 4 ↗
Sep 9	Sep 1	Eric H. L. SoExecutive Chair	Executive Chair	▲ BUY	95,000	11.80	$1.12M	+2.3%		Form 4 ↗
Sep 9	Aug 31	Paul GlavineChief Growth Officer	Chief Growth Officer	▲ BUY	90,000	11.59	$1.04M	+2.3%		Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings